Skip to main content

Animations

MJFF Publications

1741 - 1750 of 8808 Results
Title
Year
  • Year
  • 2011
  • 2014
  • 2017
  • 2017
  • 2010
  • 2006
  • 2008
  • 2015
  • 2009
  • 2009
  • Summary Details
    OPEN
    Title: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032
    Citation Count: 71
  • Summary Details
    OPEN
    Title: LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2014.00049
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Domain‐specific cognitive impairment in non‐demented Parkinson's disease psychosis
    Journal Name: International Journal of Geriatric Psychiatry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/gps.4736
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response
    Journal Name: Journal of Leukocyte Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rr
    Citation Count: 30
  • Summary Details
    OPEN
    Title: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0602116103
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jm8002153
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26302
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease
    Journal Name: Biomarkers
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3109/13547500903108423
    Citation Count: 108
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.